Mentice has announced the appointment of Frans Venker as its new CEO, effective January 1, 2025. He brings over 25 years of industry experience, with a strong background in driving innovation and growth in medical imaging and therapy solutions.
Read the full article at biostock.se:
This is a press release from BioStock – Connecting Innovation & Capital. https://www.biostock.se